The Monthly Update
If you’re following along - and why wouldn’t you be? - you would have been reading about my pride and angst over my investments and their consequences. It’s a struggle, but fun. Strange, and fun. I didn’t sell anything - much to my joy and dismay. Square has begun to trade along with Bitcoin, and Pfizer seems to have found a new life with the FDA approval of a new drug. Such is life for drug companies. It’s the risk-reward scenario that we embrace when we invest. The stock has approached its 52-week high, and I suspect that it has room to run here - and my patience is being rewarded. I no longer view the stock as a potential sell, especially with the new tax plan. Darden Restaurants reports this week. I don’t own it, but the “pin action” may translate to my favorite DelTaco (TACO) and its struggling $12 stock price. In other news, the new 21% corporate tax rate may help dissuade DelTaco’s current 40% tax rate and help them control some ...